KRAS and cancer: Among the hotspot amplifications were the regions encompassing EGFR (ch7p11),KRAS (ch12p12), and MCL1 (ch1q21), which are well-recognized cancer drivers that play crucial roles and are known to be amplified in lung adenocarcinoma [37].